Selective butyrylcholinesterase inhibitor, preparation method and use
A technology of butyrylcholinesterase and selectivity, which is applied in the direction of pharmaceutical formulations, organic active ingredients, and medical preparations containing active ingredients, etc., can solve the problems of severe AD patients' lack of drugs and patients with no available drugs, etc., to achieve The effect of high selectivity and good in vitro activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] (1) 6-(tert-butyl) 3-methyl 2-amino-4,7-dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylate (intermediate 1 )Synthesis
[0050] Take N-tert-butoxycarbonyl-4-piperidone (2g, 10.4mmol) in an eggplant-shaped bottle, dissolve it with ethanol (20mL), add methyl cyanoacetate (1.09g, 11.04mmol), and settle sulfur (0.39g , 12.05mmol) and morpholine (1.75g, 20.08mmol), heated to reflux for 3 hours, cooled to room temperature and stirred overnight, a large amount of solids were precipitated, filtered, the filter cake was washed twice with ice ethanol, dried to obtain intermediate 6- (tert-butyl) 3-methyl 2-amino-4,7-dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylate (2.42g, yield 77% ).
[0051] (2) 6-(tert-butyl)3-methyl 2-(benzenesulfonamido)-4,7-dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylic acid Synthesis of Esters (Intermediate 2)
[0052] Take 6-(tert-butyl) 3-methyl 2-amino-4,7-dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylate (intermediate 1, 0.5 g, 1.60mmol) in a...
Embodiment 2
[0057] Example 2: 6-Benzyl-2-(((4-methylphenyl)sulfonamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxy Synthesis of methyl esters:
[0058] With reference to the synthetic method of Example 1, the intermediate 2 in Example 1 is replaced by 6-(tert-butyl) 3-methyl 2-(((4-methylphenyl)sulfonyl)-4,7- Dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylate, a yellow solid compound, namely 6-benzyl-2-(((4-methylphenyl)sulfonyl Amino)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic acid methyl ester (compound 2).TLC detects as one point, there is a dark spot under the ultraviolet lamp 254nm, 365nm No fluorescence. 1 H NMR (500MHz, CDCl 3 ): δ7.79(d, J=8.2Hz, 2H), 7.40-7.30(m, 6H), 7.27(s, 1H), 3.79(s, 3H), 3.70(s, 2H), 3.52(s, 2H), 2.79(t, J=5.7Hz, 2H), 2.75(t, J=5.7Hz, 2H), 2.42(s, 3H).HRMS(ESI)m / zcalcd.for C 23 h 24 N 2 o 4 S 2 [M+H] + 456.1177, found 456.1172.
Embodiment 3
[0059] Example 3: 6-Benzyl-2-(((4-(tert-butyl)phenyl)sulfonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine- Synthesis of methyl 3-carboxylate:
[0060] With reference to the synthetic method of Example 1, intermediate 2 in Example 1 is replaced by 6-(tert-butyl) 3-methyl 2-(((4-(tert-butyl)phenyl)sulfonamido)-4 , 7-dihydrothieno[2,3-c]pyridine-3,6(5H)-dicarboxylate, to obtain a yellow solid compound, which is 6-benzyl-2-(((4-(tert-butyl base) phenyl) sulfonamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic acid methyl ester (compound 3).TLC detects as one point, UV lamp 254nm There are dark spots below and no fluorescence at 365nm. 1 H NMR (500MHz, CDCl 3 ): δ7.93(d, J=8.5Hz, 2H), 7.62(s, 1H), 7.45(d, J=8.5Hz, 2H), 7.41(t, J=6.4Hz, 3H), 7.32-7.29 (m, 2H), 4.75(s, 2H), 3.81(s, 3H), 3.55(t, J=8.3Hz, 2H), 3.26(t, J=8.4Hz, 2H), 1.32(s, 9H) .HRMS(ESI)m / z calcd.for C 26 h 30 N 2 o 4 S 2 [M+H] + 499.1647, found 499.1650.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com